EHF therapy in tuberculosis stimulates the proliferation of lymphocytes in the organs of immunogenesis, and macrophages in the bone marrow, which then intensively populate the organs affected by tuberculosis, normalize the function of external respiration and regional blood flow in the lungs, and contribute to the restoration of homeostasis. EHF therapy eliminates adverse side effects of the use of antibacterial drugs used in the treatment of tuberculosis.
EHF therapy is used for various forms of pulmonary tuberculosis: focal, infiltrative, disseminated, cavernous, fibrotic-cavernous, cirrhotic-both in newly diagnosed patients and in patients with exacerbations and relapses of the tuberculosis process, in combination with medication, physical therapy, and rational nutrition.
Used HF emitters
- Frequency 40-43 GHz, wavelength 7.1 mm (red).
- Noise-frequency 52-78 GHz (yellow).
The emitter is selected individually for each patient (adequate is the selection of the wavelength for blood parameters when irradiated “in vitro”). According to experimental data, the most effective wavelength is 7.1 mm.
Patients with severe forms of infiltrative pulmonary tuberculosis, patients with total dissemination and the presence of concomitant diseases, patients with destruction and dissemination in a single lung are recommended to have a wavelength of 7.1 mm in fractional mode.
10 procedures for 20 minutes in continuous mode or 30 minutes in fractional mode, daily.
Zone of influence: in the patient’s lying position, the emitter is installed above the thymus projection area-the sternum at the level of the intercostal space II.
Clinical effect and control
Faster resorption of infiltration in the lungs and healing of cavities than with traditional treatment. Control is carried out by clinical and radiological (x-ray, tomogram) and laboratory (microbiological research methods,biochemical and immunological blood tests) examination of the patient.
Absolute contraindications have not been identified. Relative contraindications-progressive pulmonary tuberculosis with pronounced signs of intoxication, hemoptysis (see also General contraindications for EHF therapy).
p/s Our English is not perfect . We will be happy if you point out transcription errors in comments. And you can write your questions also about this treatment protocol.